Accidental hydroxyurea over-dosage in a child with sickle cell anemia:
an African experience
Abstract
We report a case of a 34-month-old girl who has been followed up for 12
months after ingesting 105mg/kg of hydroxyurea (HU) and showed only
transient mild bone marrow suppression. With anticipated increase in HU
use among children with SCD in sub-Saharan Africa, the possibility of
accidental ingestion should be envisaged and appropriate user-education
and management guidelines established. Toxicity from accidental HU
overdosage is generally mild and transient and should not constitute a
barrier to its use in Nigerian children with SCD.